Israel’s Endospan (reported here previously) has been granted Breakthrough Device Designation from the U.S. FDA for its NEXUS Aortic Arch Stent Graft System. It already has the CE Mark of European approval.
Heart stent gets Breakthrough status
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.